Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome

Journal of Clinical Investigation

Volumn 110, Issue 1, 2002, Pages 53-60

  Hanakawa, Yasushi ^a   Schechter, Norman M ^a   Lin, Chenyan ^a   Garza, Luis ^a   Li, Hong ^a   Yamaguchi, Takayuki ^b   Fudaba, Yasuyuki ^b   Nishifuji, Koji ^c   Sugai, Motoyuki ^b   Amagai, Masayuki ^c   Stanley, John R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HIROSHIMA UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; DESMOGLEIN; EXFOLIATIN; SERINE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLISTER; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IMPETIGO BULLOSA; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; STAPHYLOCOCCUS AUREUS; STRATUM CORNEUM; TOXIC EPIDERMAL NECROLYSIS;

EID: 0036307873     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215766     Document Type: Article

References (36)

1. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome
2. The bacterial toxin toolkit
3. Cutaneous bacterial infections
4. Staphyolococcal infections
5. Staphylococcal scalded skin syndrome in adults. A clinical review illustrated with a new case
6. Staphylococcal scalded skin syndrome
7. The staphylococcal scalded-skin syndrome. Development of an experimental model
8. Staphylococcal scalded skin syndrome: The expanded clinical syndrome
9. The staphylococcal scalded-skin syndrome: Isolation and partial characterization of the exfoliative toxin
10. Site of action of exfoliative toxin in the staphylococcal scalded-skin syndrome
11. Staphylococcal toxic epidermal necrolysis: Pathogenesis and studies on the subcellular site of action of exfoliatin
12. Sequence determination and comparison of the exfoliative toxin A and toxin B genes from Staphylococcus aureus
13. Nucleotide sequence of the epidermolytic toxin A gene of Staphylococcus aureus
14. The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease
15. The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 A resolution
16. The crystal structure of exfoliative toxin B: A superantigen with enzymatic activity
17. Structural similarities and differences in Staphylococcus aureus exfoliative toxins A and B as revealed by their crystal structures
18. The epidermolytic (exfoliative) toxins of Staphylococcus aureus
19. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1
20. Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1
21. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins
22. Chemical transformation of the active-site serine residue of Streptomyces griseus trypsin to a cysteine residue
23. Recent developments in staphylococcal scalded skin syndrome
24. Mutational analysis of the superantigen staphylococcal exfoliative toxin A (ETA)
25. Staphylococcal exfoliative toxins cleave α- and βmelanocyte-stimulating hormones
26. The fate of Staphylococcal exfoliatin in newborn and adult mice
27. Conformational changes of the recombinant extracellular domain of E-cadherin upon calcium binding
28. Structural basis of calcium-induced E-cadherin rigidification and dimerization
29. Solution structure of the epithelial cadherin domain responsible for selective cell adhesion
30. A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation
31. Structure-function analysis of cell adhesion by neural (N-) cadherin
32. A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus
33. Human autoantibodies against a desmosomal core protein in pemphigus foliaceus
34. Antigen-specific immunoabsorption of pathogenic autoantibodies in pemphigus foliaceus
35. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris
36. Protection of neonases against pemphigus foliaceus by desmoglein 3